Health policy and systems research in access to medicines: A prioritized agenda for low- and middle-income countries

Health Research Policy and Systems

Volumn 11, Issue 1, 2013, Pages

  Bigdeli, Maryam ^a   Javadi, Dena ^a   Hoebert, Joelle ^b   Laing, Richard ^a   Ranson, Kent ^a   Arhinful, Daniel ^c   Jabbour, Samer ^d   Luiza, Vera Lucia ^e   Men, Chean ^f   Thi Kim, Chuc Nguyen ^g   Ntaganira, Joseph ^h   Essomba, Claudine Ntsama ⁱ   Rashidian, Arash ^j   Selvaraj, Sakhtivel ^k   Syhakhang, Lamphone ^l   Zaidi, Shehla ^m  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UTRECHT UNIVERSITY   (Netherlands)

^c University of Ghana   (Ghana)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f Centre for Advanced Studies and Chean Jaco Co   (Cambodia)

^g HANOI MEDICAL UNIVERSITY   (Viet Nam)

^h UNIVERSITY OF RWANDA   (Rwanda)

ⁱ UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^j TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^l Ministry of Health   (Laos)

^m AGA KHAN UNIVERSITY   (Pakistan)

more..

Author keywords

Access to medicines; Health systems; Health systems research; Priority setting

Indexed keywords

ARTICLE; DRUG USE; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH POLICY AND SYSTEMS RESEARCH; INFORMATION PROCESSING; MEDICAL RESEARCH; REGISTRATION; RISK MANAGEMENT;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; MEDICINE; POVERTY; PRIVATE SECTOR; WORLD HEALTH;

EID: 84885335579     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-11-37     Document Type: Article

References (33)

1. World Health Organization Everybody's Business: Strengthening Health Systems to Improve Health Outcomes. WHO's Framework for Action 2007, Geneva: World Health Organization, World Health Organization.
2. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373:240-249. 10.1016/S0140-6736(08)61762-6, 19042012.
3. World Health Organization Medicines Strategy: Countries at the Core. 2004-2007 2004, Geneva: World Health Organization, World Health Organization.
4. Mills A, Brugha R, Hanson K, Mcpake B, . Public Health Reviews What can be done about the private health sector in low-income countries?. Bull World Health Organ 2002, 80:325-330. 2567770, 12075370, Public Health Reviews.
5. Smith F. The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharm World Sci 2009, 31:351-361. 10.1007/s11096-009-9294-z, 19343530.
6. Cockburn R, Newton PN, Kyeremateng Agyarko E, Akunyili D, While NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2005, 2(4):e100. 10.1371/journal.pmed.0020100, 1062889, 15755195.
7. Burki T. The real cost of counterfeit medicines. Lancet Infect Dis 2010, 10:585-586. 10.1016/S1473-3099(10)70173-0, 20815112.
8. Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, Simons B, Bate R, Guerin PJ, White NJ. The primacy of public health considerations in defining poor quality medicines. PLoS Med 2011, 12:e1001139.
9. World Health Organization World Medicines Situation 2004, Geneva: World Health Organization, World Health Organization.
10. Taskforce on Health Systems Research Informed choices for attaining the millennium development goals: towards an international cooperative agenda for health-systems research. Lancet 2004, 364:997-1003. Taskforce on Health Systems Research.
11. Adam T, Ahmad S, Bigdeli M, Ghaffar A, Rottingen JA. Trends in health policy and systems research over the past decade: still too little capacity in low-income countries. PLOS One 2012, 6:1-10.
12. World Health Organization World Report on Knowledge for Better Health 2004, Geneva: World Health Organization, World Health Organization.
13. Ranson MK, Bennett SC. Priority setting and health policy and systems research. Health Res Policy Syst 2009, 7:27. 10.1186/1478-4505-7-27, 2796654, 19961591.
14. Commission on Health Research for Development Health Research: Essential Link to Equity in Development 1990, Oxford: Oxford University Press, Commission on Health Research for Development.
15. Kaplan W, Laing R. Priority Medicines for Europe and the World 2004, Geneva: World Health Organization.
16. World Health Organization Priority Medicines for Mothers and Children 2011, Geneva: World Health Organization, World Health Organization.
17. Proceedings of the International Conference on Improving the Use of Medicines Topic Summaries 2011, [http://www.inrud.org/icium2011-documents/upload/ICIUM2011-Theme-Summaries-16APRIL2012.pdf] Accessed 18 January 2013, Proceedings of the International Conference on Improving the Use of Medicines.
18. World Health Organization Equitable Access to Essential Medicines: A Framework for Collective Action, Policy Perspectives on Medicines 2004, 1-6. Geneva: World Health Organization, 8, World Health Organization.
19. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, Van Damme W. Access to medicines from a health system perspective. Health Policy Plan 2012, [Epub ahead of print].
20. Ranson K, Law TJ, Bennett S. Establishing health systems financing research priorities in developing countries using a participatory methodology. Social Sci Med 2010, 70:1933-1942.
21. Ranson MK, Chopra M, Atkins S, Dal Poz MR, Bennett S. Priorities for research into human resources for health in low- and middle-income countries. Bull World Health Organ 2010, 88:435-443. 10.2471/BLT.09.066290, 2878144, 20539857.
22. Gray A, Suleman F. Overview of Systematic Reviews on Pharmaceutical Policy and their Relevance to Low- and Middle-Income Countries. Report prepared for the Alliance for Health Policy and Systems Research 2009, Geneva: World Health Organization.
23. Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst 2010, 8:36. 3018439, 21159163.
24. The Working Group on Priority Setting; Council of Health Research for Development (COHRED) Priority setting for health research: lessons from developing countries. Health Policy Plan 2000, 15:130-136. 10.1093/heapol/15.2.130, 10837035, The Working Group on Priority Setting; Council of Health Research for Development (COHRED).
25. Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Effectiveness Resour Allocation 2006, 4:1-9.
26. Kapiriri L, Norheim OF. Criteria for priority-setting in health care in Uganda: exploration of stakeholders' values. Bull World Health Organ 2004, 82:172-179. 2585925, 15112005.
27. Lavis JN, Lomas J, Hamid M, Sewankambo NK. Assessing country-level efforts to link research to action. Bull World Health Organ 2006, 84:620-628. 10.2471/BLT.06.030312, 2627430, 16917649.
28. Oxman AD, Schünemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Policy Syst 2006, 4:14. 10.1186/1478-4505-4-14, 1702532, 17134481.
29. Tromp N, Baltussen R. Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers. Health Serv Res 2012, 12:454.
30. Emmerick ICM, Oliveira MA, Luiza VL, Azeredo TB, Bigdeli M. Access to medicines in Latin America and the Caribbean (LAC): a scoping study. BMJ Open 2013, 3(5):e002224. 10.1136/bmjopen-2012-002224, 3646181, 23645920.
31. Zaidi S, Bigdeli M, Aleem N, Rashidian A. Access to essential medicines in Pakistan: policy and health systems research concerns. PLoS One 2013, 8(5):e63515. 10.1371/journal.pone.0063515, 3661571, 23717442.
32. Rashidian A, Jahanmehr N, Jabbour S, Zaidi S, Soleymani F, Bigdeli M. Bibliographic analysis of research publications on access to and use of medicines in low-income and middle-income countries in the Eastern Mediterranean Region: identifying the research gaps. BMJ Open 2013, 3:e003332. 10.1136/bmjopen-2013-003332, 3796279, 24091422.
33. United Nations Millennium Development Goals [http://www.un.org/millenniumgoals/beyond2015.shtml] Accessed 3 March 2013.